GO:0036257 multivesicular body organization: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036257 (multivesicular body organization) describes the assembly, arrangement, and disassembly of the multivesicular body (MVB), a late endosome whose limiting membrane invaginates to form intraluminal vesicles (ILVs).
• The MVB is a central sorting station that decides whether membrane proteins are degraded in lysosomes or secreted as exosomes.
• ESCRT complexes (ESCRT-0 to ESCRT-III) drive cargo recognition, membrane bending, and scission during ILV formation.
• Biomolecular condensates and lipid polarization contribute to endosome membrane bending and scission, linking MVB organization to broader membrane remodeling.
• MVB dysfunction is linked to cancer, neurodegeneration, and infectious disease through altered receptor downregulation and extracellular vesicle release.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of MVB genes in human cells.
Description
Multivesicular body organization (GO:0036257) is the biological process that builds, arranges, and disassembles the multivesicular body, a specialized late endosome in which inward invagination of the limiting membrane generates internal vesicles. This organization is fundamental to endosomal sorting because membrane proteins that enter these internal vesicles are sequestered from the cytoplasm and eventually delivered to lysosomes for degradation. The MVB therefore sits at the crossroads of protein degradation, receptor downregulation, and extracellular vesicle biogenesis. Researchers study GO:0036257 to understand how cells control the fate of signaling receptors, how exosomes are formed, and how defects in these steps contribute to disease. The process depends on coordinated action of ESCRT machinery, lipid remodeling, and accessory factors that together shape the endosomal membrane. Because MVB organization influences both degradative and secretory pathways, it is a high-value target for functional genomics and CRISPR-based perturbation studies.
multivesicular body organization At A Glance
| GO ID | GO:0036257 |
|---|---|
| GO term | multivesicular body organization |
| Ontology | biological_process |
| Synonym | MVB organization |
| Major function | Assembly, arrangement, and disassembly of the multivesicular body, including intraluminal vesicle formation and cargo sequestration |
| Cellular context | Late endosome / multivesicular body |
| Key machinery | ESCRT complexes, lipid remodeling factors, and accessory proteins |
| Related processes | Endosomal sorting, lysosomal degradation, exosome biogenesis |
| Disease relevance | Cancer, neurodegeneration, and extracellular vesicle-associated pathologies |
What Is GO:0036257?
In our own words, GO:0036257 refers to the cellular process that assembles, arranges, or disassembles a multivesicular body. A multivesicular body is a late endosome characterized by inward budding of its limiting membrane, producing intraluminal vesicles that trap membrane proteins away from the cytoplasm. This definition emphasizes dynamic organization rather than a static structure, encompassing the steps that create ILVs, maintain MVB architecture, and eventually consume the MVB through fusion with lysosomes or other destinations.
Why Is multivesicular body organization Important in Cell Biology?
MVB organization is important because it determines whether signaling receptors are degraded or recycled, how extracellular vesicles are generated, and how cells communicate with their environment. Defects in this process can cause accumulation of undegraded cargo, altered signaling, and changes in exosome content, all of which have been implicated in cancer and neurodegenerative disease. Understanding GO:0036257 therefore provides mechanistic insight into fundamental endosomal biology and offers targets for therapeutic intervention.
• Controls downregulation of cell-surface receptors and termination of signaling.
• Generates intraluminal vesicles that sequester membrane proteins from the cytoplasm.
• Underpins exosome biogenesis and extracellular vesicle-mediated communication.
• Requires ESCRT-mediated membrane bending and scission.
• Involves lipid polarization and biomolecular condensates that facilitate membrane remodeling.
• Links to lysosomal degradation and cellular quality control.
• Dysregulation is associated with cancer progression and metastasis.
• Implicated in neurodegenerative conditions through impaired endolysosomal sorting.
• Provides a model for studying membrane dynamics and protein sorting.
• Offers opportunities for CRISPR-based functional screens of MVB genes.
What Happens During multivesicular body organization?
Cargo recognition and sorting at the endosomal membrane
In simple terms: The cell tags proteins that need to be degraded and sorts them into the late endosome.
During MVB organization, ubiquitinated membrane proteins are recognized by ESCRT-0 and ESCRT-I complexes at the endosomal limiting membrane. This recognition step ensures that specific cargo is concentrated in regions destined for inward budding, while other proteins are excluded. The sorting process is tightly coupled to endosome maturation and is essential for subsequent intraluminal vesicle formation.
Membrane bending and intraluminal vesicle formation
In simple terms: The endosome membrane curves inward to form small vesicles inside the endosome.
ESCRT-II and ESCRT-III complexes drive membrane deformation and scission, generating intraluminal vesicles within the MVB. Recent work has shown that biomolecular condensates can also mediate bending and scission of endosome membranes, highlighting alternative or complementary mechanisms. Lipid polarization further contributes to the membrane asymmetry required for efficient budding.
Scission and release of intraluminal vesicles
In simple terms: The newly formed vesicles pinch off and are released inside the endosome.
The final step of ILV formation requires membrane scission, which is mediated by ESCRT-III and associated factors such as VPS4. Structural studies have provided a detailed view of ESCRT-mediated abscission, revealing how the machinery constricts and cuts the membrane neck. This step is critical for sequestering cargo away from the cytoplasm.
MVB maturation and fusion with lysosomes
In simple terms: The multivesicular body matures and eventually fuses with the lysosome to degrade its contents.
After ILVs are formed, the MVB matures and can fuse with the lysosome, delivering internal vesicles and their cargo for degradation. Alternatively, MVBs can fuse with the plasma membrane to release ILVs as exosomes. The balance between these fates is regulated and influences cellular signaling and communication.
Disassembly and recycling of MVB components
In simple terms: The machinery that built the multivesicular body is taken apart and reused.
MVB organization also encompasses disassembly of the machinery and recycling of components for further rounds of sorting. ESCRT subunits are dynamically recruited and released, and their disassembly is coupled to ATP hydrolysis by VPS4. This dynamic cycle ensures that MVB organization is a reversible and regulated process.
Key Genes Involved in GO:0036257 multivesicular body organization
The following genes and proteins are central to multivesicular body organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TSG101 | ESCRT-I component involved in cargo sorting | Frequently studied in MVB and exosome research |
| VPS4A | ATPase that disassembles ESCRT-III | Key regulator of MVB scission and recycling |
| VPS4B | ATPase that disassembles ESCRT-III | Paralog of VPS4A with overlapping functions |
| CHMP4B | ESCRT-III subunit mediating membrane scission | Central to ILV formation and abscission |
| CHMP2A | ESCRT-III subunit | Involved in membrane constriction |
| VPS36 | ESCRT-II component | Cargo recognition and membrane bending |
| VPS25 | ESCRT-II component | Part of the ESCRT-II complex |
| VPS22 | ESCRT-II component | Contributes to ESCRT-II assembly |
| HRS | ESCRT-0 subunit for ubiquitinated cargo | Early sorting step in MVB organization |
| STAM1 | ESCRT-0 subunit | Cargo recognition and endosomal sorting |
| STAM2 | ESCRT-0 subunit | Cargo recognition and endosomal sorting |
| ALIX | Accessory protein for ESCRT-III recruitment | Links cargo sorting to ILV formation |
| SNF8 | ESCRT-II component | Membrane bending and cargo sorting |
| VPS28 | ESCRT-I component | Part of the ESCRT-I complex |
| VPS37A | ESCRT-I component | Cargo sorting and MVB biogenesis |
| VPS37B | ESCRT-I component | Cargo sorting and MVB biogenesis |
| VPS37C | ESCRT-I component | Cargo sorting and MVB biogenesis |
How Is multivesicular body organization Regulated?
MVB organization is regulated by the dynamic assembly and disassembly of ESCRT complexes, which is controlled by ATP hydrolysis and post-translational modifications. Lipid composition, including phosphatidylinositol 3-phosphate and other lipids, influences the recruitment of ESCRT components and membrane bending. Biomolecular condensates can also regulate membrane bending and scission, adding a layer of spatial control. Additionally, the balance between lysosomal degradation and exosomal secretion is modulated by signaling pathways that affect MVB maturation and fusion.
multivesicular body organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TSG101 | Cancer progression and exosome biogenesis | Knockout in cancer cell lines |
| VPS4A | Neurodegeneration and endosomal sorting defects | Point mutation knock-in in neuronal cells |
| CHMP4B | Cancer and membrane remodeling | Overexpression in HeLa cells |
| ALIX | Cancer and exosome release | Knockout in HEK293T cells |
| HRS | Neurodegeneration and receptor downregulation | Knockout in primary neurons |
Cancer and extracellular vesicles
Alterations in MVB organization can change the cargo and abundance of exosomes, which are extracellular vesicles that promote tumor progression and metastasis. ESCRT components are frequently dysregulated in cancers, affecting receptor downregulation and signaling.
Neurodegeneration
Impaired endosomal sorting and MVB organization have been linked to neurodegenerative diseases, where defective clearance of proteins contributes to neuronal toxicity. Disruption of ESCRT function can lead to accumulation of undegraded cargo and altered exosome release.
Infectious disease and viral budding
Many enveloped viruses exploit ESCRT machinery for budding, highlighting the importance of MVB organization in viral replication and release. Understanding these interactions may inform antiviral strategies.
From multivesicular body organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TSG101 affect MVB formation? | CRISPR knockout in HeLa or HEK293T cells |
| How do point mutations in VPS4A alter ESCRT disassembly? | Point mutation knock-in in U2OS cells |
| Can tagged ESCRT-III be used to track ILV dynamics? | Knock-in of fluorescent tags in CHMP4B |
| Does overexpression of ALIX increase exosome release? | Overexpression in cancer cell lines |
| Which genes regulate MVB organization in neurons? | CRISPR library screening in iPSC-derived neurons |
| How does lipid composition affect MVB budding? | Knockout of lipid-modifying enzymes in HeLa cells |
How to Study the multivesicular body organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electron microscopy | Ultrastructure of MVBs and ILVs | Visualizing MVB morphology |
| Live-cell imaging | Dynamic ESCRT recruitment | Tracking MVB organization in real time |
| Proteomics | Protein composition of MVBs | Identifying cargo and machinery |
| CRISPR knockout screens | Gene requirement for MVB organization | Discovering novel regulators |
| Exosome isolation | Extracellular vesicle release | Linking MVB to secretion |
| Co-immunoprecipitation | Protein-protein interactions | Mapping ESCRT complexes |
| Flow cytometry | Receptor downregulation | Measuring MVB-dependent degradation |
| RNA-seq | Transcriptional changes upon MVB perturbation | Pathway analysis |
Imaging-based analysis of MVB organization
Electron microscopy and live-cell fluorescence imaging are used to visualize intraluminal vesicles and track ESCRT dynamics. Super-resolution microscopy can resolve the nanoscale architecture of MVBs.
Proteomic and biochemical assays
Proteomics and immunoblotting can identify cargo and ESCRT components associated with MVBs. Co-immunoprecipitation and mass spectrometry reveal interaction networks.
Functional genomics and CRISPR screens
CRISPR knockout and activation screens enable systematic discovery of genes required for MVB organization and exosome release. These screens can be coupled with flow cytometry or sequencing-based readouts.
Exosome and extracellular vesicle analysis
Isolation and characterization of exosomes by nanoparticle tracking, Western blotting, and RNA profiling link MVB organization to extracellular vesicle output.
How CRISPR Can Be Used to Study GO:0036257 multivesicular body organization
Knockout
CRISPR knockout of ESCRT genes such as TSG101 or CHMP4B disrupts MVB organization, leading to impaired receptor degradation and altered exosome release. These models are valuable for studying loss-of-function phenotypes in human cells.
Point Mutation
Point mutations in genes like VPS4A can be introduced to mimic disease-associated variants or to dissect catalytic residues required for ESCRT disassembly. Such models help distinguish between loss-of-function and gain-of-function effects.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous ESCRT loci allows real-time tracking of protein localization and dynamics during MVB organization. This approach preserves native regulation and expression levels.
Overexpression
Overexpression of MVB-related genes such as ALIX or CHMP4B can enhance or perturb ILV formation and exosome secretion, providing gain-of-function models for mechanistic studies.
How EDITGENE Supports multivesicular body organization Research
Researchers studying multivesicular body organization-related genes often need to determine whether a candidate gene is causally involved in MVB assembly, cargo sorting, or exosome release. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for multivesicular body organization research.
Frequently Asked Questions About multivesicular body organization
What is multivesicular body organization?
It is the cellular process that assembles, arranges, and disassembles the multivesicular body, a late endosome that forms internal vesicles to sequester membrane proteins.
What genes are involved in multivesicular body organization?
Key genes include ESCRT components such as TSG101, VPS4A, CHMP4B, and accessory proteins like ALIX.
What is the role of ESCRT in MVB organization?
ESCRT complexes recognize cargo, bend the endosomal membrane, and mediate scission to form intraluminal vesicles.
How is multivesicular body organization linked to exosomes?
MVBs can fuse with the plasma membrane to release intraluminal vesicles as exosomes, linking MVB organization to extracellular communication.
What diseases are associated with defective MVB organization?
Cancer, neurodegeneration, and viral infections have been linked to altered MVB function.
What methods are used to study MVB organization?
Electron microscopy, live-cell imaging, proteomics, and CRISPR screens are commonly used.
Can CRISPR be used to study MVB genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional dissection of MVB genes.
What is the GO ID for multivesicular body organization?
The GO ID is GO:0036257.
What is the definition of GO:0036257?
It is a biological process that results in the assembly, arrangement, or disassembly of a multivesicular body.
Why is MVB organization important for cell signaling?
It controls the degradation of signaling receptors, thereby regulating signal duration and intensity.
Conclusion
Multivesicular body organization (GO:0036257) is a dynamic and essential process that governs endosomal sorting, receptor downregulation, and extracellular vesicle biogenesis. Its molecular machinery, centered on ESCRT complexes and lipid remodeling, has been increasingly resolved through structural and functional studies. Dysregulation of this process contributes to cancer, neurodegeneration, and infectious disease, making it a compelling area for therapeutic targeting. CRISPR-based models offer powerful tools to dissect the causal roles of individual genes in MVB organization and to identify new regulatory nodes.
References
- 1. Scott CC et al.. 2014. Endosome maturation, transport and functions.. Semin Cell Dev Biol 31:2-10 PMID: 24709024
- 2. Wang Y et al.. 2024. Biomolecular condensates mediate bending and scission of endosome membranes.. Nature 634(8036):1204-1210 PMID: 39385023
- 3. Kunduri G et al.. 2022. Lipid Polarization during Cytokinesis.. Cells 11(24) PMID: 36552741
- 4. Horváth P et al.. 2020. A Structural View on ESCRT-Mediated Abscission.. Front Cell Dev Biol 8:586880 PMID: 33240884
- 6. Tran PH et al.. 2020. Aptamer-guided extracellular vesicle theranostics in oncology.. Theranostics 10(9):3849-3866 PMID: 32226524
- 7. Jouvenet N. 2012. Dynamics of ESCRT proteins.. Cell Mol Life Sci 69(24):4121-33 PMID: 22669260
- 8. Mayorga LS et al.. 2024. The Secret Ballet Inside Multivesicular Bodies.. ACS Nano 18(24):15651-15660 PMID: 38830824
